Download Now: 7 Unstoppable Growth Engines of India's $10 Trillion Bull Run...
Here is the latest financial fact sheet of BROOKS LAB. For more details, see the BROOKS LAB quarterly results and BROOKS LAB share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 2.0 |
No. of shares | m | 26.25 |
1 Week | % | 8.2 |
1 Month | % | 12.3 |
1 Year | % | 73.8 |
52 week H/L | Rs | 185.2/56.5 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
BROOKS LAB EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 123 | 63 | 78 | 155 | 142 | |
Low | Rs | 38 | 14 | 16 | 60 | 58 | |
Sales per share (Unadj.) | Rs | 34.0 | 28.2 | 31.3 | 36.9 | 25.6 | |
Earnings per share (Unadj.) | Rs | -9.1 | -9.9 | -7.8 | -7.8 | -12.6 | |
Diluted earnings per share | Rs | -5.6 | -9.3 | -7.4 | -7.4 | -11.8 | |
Cash flow per share (Unadj.) | Rs | -5.1 | -7.2 | -5.0 | -4.8 | -9.7 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 61.5 | 39.8 | 32.0 | 35.4 | 29.9 | |
Adj. book value per share | Rs | 37.9 | 37.5 | 30.2 | 33.3 | 28.2 | |
Shares outstanding (eoy) | m | 16.19 | 24.70 | 24.70 | 24.70 | 24.70 | |
Price / Sales ratio | x | 2.4 | 1.4 | 1.5 | 2.9 | 3.9 | |
Avg P/E ratio | x | -8.8 | -3.9 | -6.0 | -13.7 | -7.9 | |
P/CF ratio (eoy) | x | -15.7 | -5.4 | -9.5 | -22.2 | -10.3 | |
Price / Book Value ratio | x | 1.3 | 1.0 | 1.5 | 3.0 | 3.3 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 1,302 | 957 | 1,157 | 2,654 | 2,466 | |
Total wages/salary | Rs m | 100 | 112 | 120 | 169 | 160 |
BROOKS LAB INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 550 | 697 | 772 | 912 | 632 | |
Other income | Rs m | 29 | 4 | 7 | 8 | 2 | |
Total revenues | Rs m | 579 | 701 | 780 | 920 | 634 | |
Gross profit | Rs m | -84 | -39 | 5 | -143 | -294 | |
Depreciation | Rs m | 65 | 66 | 71 | 74 | 70 | |
Interest | Rs m | 30 | 34 | 31 | 31 | 22 | |
Profit before tax | Rs m | -149 | -135 | -90 | -239 | -384 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | -1 | 109 | 104 | -46 | -73 | |
Profit after tax | Rs m | -148 | -244 | -194 | -193 | -311 | |
Gross profit margin | % | -15.2 | -5.6 | 0.7 | -15.6 | -46.5 | |
Effective tax rate | % | 1.0 | -80.4 | -115.4 | 19.2 | 19.1 | |
Net profit margin | % | -26.9 | -35.0 | -25.1 | -21.2 | -49.1 |
BROOKS LAB BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 317 | 379 | 474 | 612 | 276 | |
Current liabilities | Rs m | 474 | 458 | 636 | 489 | 330 | |
Net working cap to sales | % | -28.4 | -11.3 | -21.0 | 13.5 | -8.6 | |
Current ratio | x | 0.7 | 0.8 | 0.7 | 1.3 | 0.8 | |
Inventory Days | Days | 51 | 36 | 18 | 33 | 387 | |
Debtors Days | Days | 757 | 815 | 647 | 707 | 737 | |
Net fixed assets | Rs m | 1,252 | 1,199 | 1,122 | 1,334 | 820 | |
Share capital | Rs m | 162 | 247 | 247 | 247 | 247 | |
"Free" reserves | Rs m | 834 | 737 | 544 | 628 | 493 | |
Net worth | Rs m | 996 | 984 | 791 | 875 | 740 | |
Long term debt | Rs m | 139 | 114 | 144 | 93 | 0 | |
Total assets | Rs m | 1,570 | 1,579 | 1,621 | 1,946 | 1,096 | |
Interest coverage | x | -4.0 | -3.0 | -1.9 | -6.7 | -16.6 | |
Debt to equity ratio | x | 0.1 | 0.1 | 0.2 | 0.1 | 0 | |
Sales to assets ratio | x | 0.4 | 0.4 | 0.5 | 0.5 | 0.6 | |
Return on assets | % | -7.5 | -13.3 | -10.0 | -8.3 | -26.3 | |
Return on equity | % | -14.9 | -24.8 | -24.5 | -22.1 | -42.0 | |
Return on capital | % | -10.6 | -9.3 | -6.3 | -21.5 | -48.9 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx outflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Net fx | Rs m | 0 | 0 | 0 | 0 | 0 |
BROOKS LAB CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -50 | -94 | 45 | -374 | -145 | |
From Investments | Rs m | 11 | -23 | -51 | -249 | 5 | |
From Financial Activity | Rs m | 58 | 96 | 12 | 641 | 114 | |
Net Cashflow | Rs m | 19 | -21 | 5 | 17 | -26 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Atul Ranchal | COMP SEC: Jai Vaidya | YEAR OF INC: 2002 | BSE CODE: 533543 | FV (Rs): 10 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare BROOKS LAB With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.